• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产 KPC-2 碳青霉烯酶肠杆菌科细菌的美罗培南与头孢美唑联合治疗的疗效评估

Effectiveness of Meropenem and Cefmetazole Combination Treatment Against KPC-2-Producing .

机构信息

1 Department of Infection Control and Prevention, Graduate School of Medicine, Osaka University, Osaka, Japan.

2 Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan.

出版信息

Microb Drug Resist. 2019 Jul/Aug;25(6):839-845. doi: 10.1089/mdr.2018.0397. Epub 2019 Mar 5.

DOI:10.1089/mdr.2018.0397
PMID:30835635
Abstract

Optimal treatment regimens are yet to be established for carbapenemase-producing (CPE). We assessed the efficacy of meropenem (MEM) and cefmetazole (CMZ) combination treatment against -positive , in comparison with that of double-carbapenem therapy using ertapenem (ERT). We performed checkerboard assay for 10 -positive clinical isolates and BAA-1705 (possessing ), with synergistic effect being defined by a fractional inhibitory concentration index of ≤0.5. Subsequently, we conducted time-kill assays using BAA-1705 with an initial inoculum of 10-10 colony forming unit (CFU)/mL. Bactericidal effect was defined as the reduction of initial bacterial count by ≥10 CFU/mL in 24 hr. Finally, we applied scanning electron microscopy to observe morphological changes induced by the combination of MEM and CMZ. Checkerboard assays revealed a synergistic effect in 7 out of 11 -positive when the MEM and CMZ combination was used, and no effect when the MEM and ERT combination was used. The minimum inhibitory concentration of MEM decreased 4-8-fold when combined with CMZ. Time-kill assays with an initial inoculum of 5 × 10 CFU/mL revealed regrowth under the combination of MEM and ERT (0.25 × minimum inhibitory concentration [MIC] each), whereas the combination of 0.25 × MIC each of MEM and CMZ exhibited bactericidal effect. Scanning electron microscopy results demonstrated that the combination of 0.5 × MIC MEM and 0.5 × MIC CMZ facilitated bacterial cell lysis compared with each antibiotic alone. The combination therapy using MEM and CMZ potentially has bactericidal effect against KPC-producing .

摘要

针对产碳青霉烯酶(CPE)的治疗方案仍有待确立。我们评估了美罗培南(MEM)和头孢美唑(CMZ)联合治疗与厄他培南(ERT)双重碳青霉烯治疗相比对 -阳性的疗效。我们对 10 株 -阳性临床分离株和 BAA-1705(携带)进行棋盘微量稀释法检测,协同作用定义为分数抑菌浓度指数≤0.5。随后,我们使用初始接种物为 10-10 菌落形成单位(CFU)/mL 的 BAA-1705 进行时间杀伤试验。杀菌效果定义为在 24 小时内初始细菌计数减少≥10 CFU/mL。最后,我们应用扫描电子显微镜观察 MEM 和 CMZ 联合使用诱导的形态变化。棋盘微量稀释法检测结果显示,在 11 株 -阳性菌株中,MEM 和 CMZ 联合使用时有 7 株表现出协同作用,而 MEM 和 ERT 联合使用时则无协同作用。MEM 与 CMZ 联合使用时,MEM 的最低抑菌浓度降低了 4-8 倍。当初始接种物为 5×10 CFU/mL 时,MEM 和 ERT 联合使用(MEM 和 ERT 各为 0.25×最低抑菌浓度 [MIC])会出现再生长,而 MEM 和 CMZ 各为 0.25×MIC 的联合使用则表现出杀菌作用。扫描电子显微镜结果表明,与单独使用每种抗生素相比,0.5×MIC MEM 和 0.5×MIC CMZ 的联合使用促进了细菌细胞裂解。MEM 和 CMZ 联合治疗可能对产 KPC 的具有杀菌作用。

相似文献

1
Effectiveness of Meropenem and Cefmetazole Combination Treatment Against KPC-2-Producing .产 KPC-2 碳青霉烯酶肠杆菌科细菌的美罗培南与头孢美唑联合治疗的疗效评估
Microb Drug Resist. 2019 Jul/Aug;25(6):839-845. doi: 10.1089/mdr.2018.0397. Epub 2019 Mar 5.
2
In Vitro Efficacy of Meropenem-Cefmetazole Combination Therapy against New Delhi Metallo-β-lactamase-producing Enterobacteriaceae.体外美罗培南-头孢美唑联合治疗对产新德里金属β-内酰胺酶肠杆菌科的疗效。
Int J Antimicrob Agents. 2020 Mar;55(3):105905. doi: 10.1016/j.ijantimicag.2020.105905. Epub 2020 Jan 25.
3
Bactericidal efficacy of meropenem in combination with cefmetazole against IMP-producing carbapenem-resistant Enterobacteriaceae.美罗培南联合头孢美唑对产 IMP 的耐碳青霉烯类肠杆菌科细菌的杀菌效果。
BMC Res Notes. 2019 Nov 9;12(1):740. doi: 10.1186/s13104-019-4779-x.
4
Effect of ceftazidime-avibactam combined with different antimicrobials against carbapenem-resistant .头孢他啶-阿维巴坦联合不同抗菌药物对碳青霉烯类耐药. 的影响。
Microbiol Spectr. 2024 Jun 4;12(6):e0010724. doi: 10.1128/spectrum.00107-24. Epub 2024 May 7.
5
In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing .头孢他啶-阿维巴坦对产碳青霉烯酶的. 的体外和体内杀菌活性。
Antimicrob Resist Infect Control. 2018 Nov 21;7:142. doi: 10.1186/s13756-018-0435-9. eCollection 2018.
6
Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.采用小鼠大腿感染模型,对美罗培南、头孢吡肟或氨曲南与新型β-内酰胺酶抑制剂那库巴坦联合用药,针对耐碳青霉烯类和/或产碳青霉烯酶的肺炎克雷伯菌和大肠埃希菌进行药效学评价。
Int J Antimicrob Agents. 2021 May;57(5):106330. doi: 10.1016/j.ijantimicag.2021.106330. Epub 2021 Mar 28.
7
Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC.Nacubactam 增强美罗培南对产 KPC 碳青霉烯类耐药肺炎克雷伯菌的活性。
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.00432-19. Print 2019 Aug.
8
Role of Double-Carbapenem Regimen in the Treatment of Infections due to Carbapenemase Producing Carbapenem-Resistant : A Single-Center, Observational Study.产碳青霉烯酶碳青霉烯类耐药菌感染的治疗中双联碳青霉烯方案的作用:一项单中心、观察性研究。
Biomed Res Int. 2018 Nov 18;2018:2785696. doi: 10.1155/2018/2785696. eCollection 2018.
9
In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains.体外评估双重碳青霉烯类和黏菌素组合对产 OXA-48、NDM 碳青霉烯酶的黏菌素耐药肺炎克雷伯菌的作用。
Antimicrob Resist Infect Control. 2020 May 19;9(1):70. doi: 10.1186/s13756-020-00727-4.
10
Frequency Determination of Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) Isolated from hospitals in Isfahan of Iran and Evaluation of Synergistic Effect of Colistin and Meropenem on them.从伊朗伊斯法罕医院分离出的耐碳青霉烯肺炎克雷伯菌(CRKP)的频率测定及黏菌素与美罗培南对其协同作用的评估。
Cell Mol Biol (Noisy-le-grand). 2018 Jan 31;64(1):70-74. doi: 10.14715/cmb/2018.64.1.13.

引用本文的文献

1
Deciphering the Intricate Interplay in the Framework of Antibiotic-Drug Interactions: A Narrative Review.解读抗生素-药物相互作用框架中的复杂相互作用:一篇叙述性综述
Antibiotics (Basel). 2024 Oct 5;13(10):938. doi: 10.3390/antibiotics13100938.
2
Short Antimicrobial Peptide Derived from the Venom Gland Transcriptome of Increases Gentamicin Susceptibility of Multidrug-Resistant .源自毒液腺转录组的短抗菌肽增强多重耐药菌对庆大霉素的敏感性。
Antibiotics (Basel). 2023 Dec 20;13(1):6. doi: 10.3390/antibiotics13010006.
3
Asymptomatic gastrointestinal carriage of multidrug-resistant carbapenemase-producing Enterobacteriaceae among children under five years in a Kenyan hospital.
肯尼亚一家医院5岁以下儿童中耐多药产碳青霉烯酶肠杆菌科细菌的无症状胃肠道携带情况。
IJID Reg. 2023 Sep 27;9:25-31. doi: 10.1016/j.ijregi.2023.07.007. eCollection 2023 Dec.
4
Losing the Battle but Winning the War: Can Defeated Antibacterials Form Alliances to Combat Drug-Resistant Pathogens?虽败犹胜:落败的抗菌药物能否结成联盟对抗耐药病原体?
Antibiotics (Basel). 2021 May 28;10(6):646. doi: 10.3390/antibiotics10060646.
5
In vitro and in vivo Effect of Antimicrobial Agent Combinations Against Carbapenem-Resistant with Different Resistance Mechanisms in China.抗菌药物联合应用对中国不同耐药机制碳青霉烯类耐药菌的体外和体内作用
Infect Drug Resist. 2021 Mar 5;14:917-928. doi: 10.2147/IDR.S292431. eCollection 2021.
6
Bactericidal efficacy of meropenem in combination with cefmetazole against IMP-producing carbapenem-resistant Enterobacteriaceae.美罗培南联合头孢美唑对产 IMP 的耐碳青霉烯类肠杆菌科细菌的杀菌效果。
BMC Res Notes. 2019 Nov 9;12(1):740. doi: 10.1186/s13104-019-4779-x.